ELDON
Eldon Biologicals A/S is a Danish medical device manufacturer that produces the EldonCard, a dry-format point-of-care blood typing card for ABO and Rhesus D determination, serving hospitals, militaries, NGOs, and consumers via a global distributor network and Amazon.
- Company typePrivate
- Founded-
- HeadquartersGentofte, Denmark
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What ELDON does
Eldon Biologicals A/S is a privately held Danish medical device manufacturer headquartered in Gentofte, north of Copenhagen. The company produces the EldonCard, a dry-format blood typing card using dried monoclonal antibody formulations on special plastic to determine ABO and Rhesus D blood groups at the point of care. The product requires only 5 µl of whole blood, delivers results in approximately two minutes, has a 24-month shelf life at 5–37 °C without refrigeration, and is validated to 99.9% concordance with standard laboratory methods across multi-country studies. The EldonCard is ISO 13485 certified, CE marked in the EU, cleared by the US FDA, and listed on the WHO Essential Diagnostics List and the WHO Compendium of Innovative Health Technologies for Low-Resource Settings.
The company's product portfolio centers on the core EldonCard and includes a dedicated Rhesus card for maternal health settings, a single-use safety lancet, and a home blood type testing kit sold through Amazon. Eldon Biologicals earns revenue primarily through one-time sales of cards and accessories to healthcare providers, hospitals, military medical units, NGOs, and clinical laboratories, channeled through a global authorized distributor network spanning more than 40 countries across Europe, Africa, Asia, North America, South America, and Oceania; consumer home kits are sold directly through the Amazon marketplace. Commercial pricing is not publicly disclosed and is negotiated through distributors.
Eldon Biologicals maintains a small operational footprint (reported headcount of 1–10) and pursues impact-oriented partnerships with institutions including UNICEF, the Leiden University Medical Centre, Sanquin, the Kenya Obstetrical and Gynecological Society, the AFRICARhE Consortium, WIRhE, and tactical-medicine programs in Ukraine, focused on Rhesus disease prevention, postpartum hemorrhage management, and field blood typing.
ELDON firmographics
Firmographics- Name
- ELDON
- Legal name
- Eldon Biologicals A/S
- Website
- https://eldoncard.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Eldon Biologicals A/S is a Danish medical device manufacturer that produces the EldonCard, a dry-format point-of-care blood typing card for ABO and Rhesus D determination, serving hospitals, militaries, NGOs, and consumers via a global distributor network and Amazon.
- Ownership category
- akta.pro rank
ELDON industry classification
Industry- Product category
- In-Vitro Diagnostic Medical Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)
- akta.pro secondary industry
- Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)
Keywords
Where ELDON is headquartered
LocationHeadquarters
- HQ city
- Gentofte
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
ELDON business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Medical Device Sales: Sale of EldonCards and related blood typing products to healthcare providers, hospitals, military medical units, and clinical laboratories globally through distributor network.
- Consumer/Home Testing Kits: Direct-to-consumer sales of home blood type testing kits through Amazon marketplace for individual users wanting to know their blood type.
Go-to-market motion3 records
Distribution channels2 records
Marketing channels3 records
ELDON product offering
Product offeringCore offering
Eldon Biologicals A/S manufactures and sells the EldonCard product line, a dry-format point-of-care blood typing system for ABO and Rhesus D blood grouping. The cards use dried monoclonal antibody formulations on special plastic substrates and deliver blood type results in approximately 2 minutes from as little as 5 µl of whole blood, without refrigeration or laboratory infrastructure. The portfolio serves healthcare providers, military medical units, maternal health programs, NGOs, and individual consumers through a global distributor network and Amazon home-test kits.
Product overview
Eldon Biologicals A/S manufactures and sells the EldonCard product line—a dry format blood typing system for ABO and Rhesus (D) blood grouping. The core EldonCard product consists of plastic cards with dried monoclonal antibody formulations that provide rapid, point-of-care blood type determination without requiring refrigeration or laboratory equipment. The portfolio includes the standard EldonCard, the Home Kit for personal blood type testing, the specialized Rhesus Card for maternal health settings, and single-use safety lancets. The system is designed for both professional medical use and home testing, delivering results in 2 minutes from minimal blood samples.
Differentiator
Problem solved
Functional benefit
Products and services
- EldonCard Dry-format plastic card with dried monoclonal antibody reagents used for point-of-care ABO and Rhesus D blood grouping. Provides blood type results in 2 minutes from 5 µl of whole blood without refrigeration or laboratory equipment; shelf life 24 months at 5–37 °C; ISO 13485, CE marked, US FDA cleared.
- Eldon Blood Type Test (Home Kit) Consumer home blood typing kit containing an EldonCard with four circles of dried antibody reagents plus an instructions guide for interpreting agglutination patterns. Sold directly to individual consumers via Amazon for personal blood type determination.
- Eldon Safety Lancet Disposable single-use safety lancet with a post-use activation safety mechanism that prevents accidental piercing, used to draw the small whole-blood sample required for the EldonCard test.
- EldonCard Rhesus Card Specialized EldonCard variant designed for Rhesus status screening of pregnant women in birth centres, birth clinics, and abortion clinics to support Rhesus disease prophylaxis and maternal health programs.
Quantifiable outcome
- 99.9% concordance with standard blood typing procedures in multi-country laboratory validation studies
- +3 more outcomes
Companies that use ELDON
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
ELDON technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ELDON partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- PULSE - Tactical Medicine for UkrainecorePartnership for pre-hospital blood transfusion training for Ukrainian Armed Forces. EldonCards used for rapid blood type determination in combat medicine scenarios, enabling timely life-saving transfusions.
- UNICEFcorePartnership to provide UNICEF with EldonCards as a tool strengthening maternal and child health programs across UNICEF's operations in over 190 countries.
- DonorUAcoreUkrainian blood donor organization partnership for Walking Blood Bank initiative. Donor registration and free blood type testing using EldonCards at outreach activities.
- AFRICARhE ConsortiumcoreThree-country initiative in Ethiopia, Malawi, and Tanzania involving LUMC, Sanquin, Haramaya University, Hiwot Fana Specialized University Hospital, Queen Elizabeth Central Hospital, and Kilimanjaro Christian Medical Centre. Blood type testing of 10,000 pregnant women per country.
- Caritas AfricaminorPresentation of EldonCard at Caritas Africa General Assembly in Rome. Discussions on Rhesus disease prevention and blood donor mobilization across African healthcare systems.
- Kenya Obstetrical and Gynecological Society (KOGS)coreEU-funded pilot project implementing Rhesus disease prevention through blood type testing of pregnant women using EldonCards. Part of the broader End PPH Project targeting postpartum hemorrhage.
- Walking Blood Bank UkrainecorePartnership with DonorUA and Yashchenko Foundation to develop and expand Walking Blood Bank in Ukraine, addressing shortage of donor blood through rapid blood type testing and donor registration.
- End PPH ProjectcorePartnership including KOGS, Midwifes Association of Kenya, University of Nairobi to tackle postpartum hemorrhage - a leading cause of maternal mortality in Kenya (25-45% of maternal deaths). EldonCards support blood donor mobilization.
- SanquincoreDutch blood services provider collaborating on African Rhesus disease prevention projects. Discussed cooperation focusing on field testing and scaling up Rhesus disease prevention in Ethiopia, Malawi, and Tanzania.
- Leiden University Medical Centre (LUMC)coreLeading global initiative to eradicate Hemolytic Disease of the Fetus and Newborn (HDFN/Rhesus disease). Developed two-phase study to tackle the disease in sub-Saharan Africa.
- WIRhE (Worldwide Initiative for Rh Disease Eradication)coreGlobal partnership dedicated to Rhesus disease eradication. Eldon Biologicals supports efforts with point-of-care testing technology for screening and prevention programs.
- Protected Workplaces for Disabled EmploymentminorCooperation with seven different protected workplaces providing genuine employment opportunities for people living with disabilities in production and assembly.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
ELDON competitors and assessment
Company assessmentBroad incumbents
- Bio-Rad Laboratories: Bio-Rad's DiaMed line supplies blood typing reagents, gel cards, and instrumentation used in transfusion medicine. As a broad diagnostics incumbent, Bio-Rad overlaps with Eldon in the same clinical workflow but offers a much wider product portfolio.
- Siemens Healthineers: Siemens Healthineers offers blood typing and immunohematology solutions as part of its central lab diagnostics franchise. It targets the same clinical use case as EldonCard but via high-throughput analyzers in established lab environments.
- Grifols Diagnostic Solutions: Grifols produces blood typing reagents and is a major player in transfusion diagnostics as part of its broader plasma and diagnostics business. It competes with Eldon in the same clinical indication but with a portfolio-focused, integrated blood bank offering.
- Abbott Diagnostics: Abbott is a global diagnostics incumbent offering blood typing and transfusion-related assays as part of its broader core lab and POC portfolio. It competes with Eldon for hospital transfusion medicine budgets, though ABO/Rhesus is a small slice of its portfolio.
- Ortho Clinical Diagnostics (QuidelOrtho): QuidelOrtho manufactures immunohematology reagents and the ORTHO VISION analyzer for blood banks. It addresses the same clinical need as EldonCard (ABO/Rhesus determination) but is geared toward centralized hospital labs rather than field point-of-care use.
Direct peers
- Immucor (Werfen): Immucor, now part of Werfen, is a global leader in transfusion and immunohematology diagnostics, offering manual and automated blood typing reagents and instruments. It is the most direct large-scale competitor to EldonCard in hospital blood bank workflows.
- Quotient Limited: Quotient develops the MosaiQ blood transfusion diagnostics platform for donor typing and patient screening. It competes with EldonCard at the immunohematology testing step in blood banks, though via a higher-throughput centralized instrument rather than a point-of-care card.
- Silver Lake Research (Typenex): Silver Lake Research markets the Typenex home blood typing kit, a direct analogue of Eldon's Amazon home kit. It is the closest pure-play comparable in the consumer blood typing segment where Eldon also competes.
Emerging players
- HemoCue (Radiometer/Danaher): HemoCue provides point-of-care blood diagnostics (notably hemoglobin and glucose) for field and primary care settings. While not a direct blood typing competitor, it is comparable as a small-format, no-refrigeration POC diagnostics brand addressing similar low-resource and emerging-market customers.
- Biomedomics: Biomedomics develops point-of-care blood typing tests targeted at low-resource settings, including a lateral flow typing device. It is the closest emerging direct competitor to EldonCard in field/decentralized blood typing use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ELDON social profiles
Digital presenceELDON compliance and trust
Trust signalCompliance3 records
ELDON financial estimates
Financial estimateRevenue estimate
Valuation estimate
ELDON leadership team
Management profileNumber of profiles
Profiles4 records
ELDON funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ELDON M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ELDON
What does ELDON do?
Eldon Biologicals A/S manufactures and sells the EldonCard product line, a dry-format point-of-care blood typing system for ABO and Rhesus D blood grouping. The cards use dried monoclonal antibody formulations on special plastic substrates and deliver blood type results in approximately 2 minutes from as little as 5 µl of whole blood, without refrigeration or laboratory infrastructure. The portfolio serves healthcare providers, military medical units, maternal health programs, NGOs, and individual consumers through a global distributor network and Amazon home-test kits.
Is ELDON a public or private company?
ELDON is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ELDON founded?
ELDON was founded in -1. It employs 1 to 10 people.
Where is ELDON based?
ELDON is headquartered in Gentofte, Denmark, in the Europe region.
How does ELDON make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are consumer/Home Testing Kits.
Who are ELDON's main competitors?
Broad incumbents on record are Bio-Rad Laboratories, Siemens Healthineers, Grifols Diagnostic Solutions, Abbott Diagnostics and Ortho Clinical Diagnostics (QuidelOrtho). Direct peers are Immucor (Werfen), Quotient Limited and Silver Lake Research (Typenex). Emerging players are HemoCue (Radiometer/Danaher) and Biomedomics.
Does ELDON have an API?
No public API is recorded for ELDON.
What industry is ELDON in?
ELDON's product category is In-Vitro Diagnostic Medical Devices. Its primary akta.pro industry code is HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology, with a secondary code of HLAFAMAG, Transfusion Medicine & Immunohematology (Blood Bank). Its NAICS code is 325413 and its SIC code is 2835.